Polaris Group (TPE: 6550)

Market Cap	42.35B
Revenue (ttm)	65.53M
Net Income (ttm)	-1.96B
Shares Out	745.68M
EPS (ttm)	-2.63
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	497,338
Open	57.90
Previous Close	57.60
Day's Range	56.60 - 58.00
52-Week Range	51.80 - 87.70
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Polaris Group

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications. It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 165
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6550

Financial Performance

In 2023, Polaris Group's revenue was 7.48 million, an increase of 16.18% compared to the previous year's 6.44 million. Losses were -1.58 billion, 37.1% more than in 2022.